Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05733598
Title RP3 in Combination With 1L or 2L Therapy in Patients With Locally Advanced Unresectable or Metastatic HCC
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Replimune Inc.
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | DEU

No variant requirements are available.